Veldman C - Search Results

1

Detection of low avidity desmoglein 3-reactive T cells in pemphigus vulgaris using HLA-DR beta 1*0402 tetramers.

Veldman C, Eming R, Wolff-Franke S, Sonderstrup G, Kwok WW, Hertl M. Veldman C, et al. Clin Immunol. 2007 Mar;122(3):330-7. doi: 10.1016/j.clim.2006.09.014. Epub 2006 Nov 17. Clin Immunol. 2007. PMID: 17113829

2

Type I regulatory T cells specific for desmoglein 3 are more frequently detected in healthy individuals than in patients with pemphigus vulgaris.

Veldman C, Höhne A, Dieckmann D, Schuler G, Hertl M. Veldman C, et al. J Immunol. 2004 May 15;172(10):6468-75. doi: 10.4049/jimmunol.172.10.6468. J Immunol. 2004. PMID: 15128839

3

Desmoglein 3-specific T regulatory 1 cells consist of two subpopulations with differential expression of the transcription factor Foxp3.

Veldman C, Pahl A, Hertl M. Veldman C, et al. Immunology. 2009 May;127(1):40-9. doi: 10.1111/j.1365-2567.2008.02932.x. Immunology. 2009. Retraction in: Immunology. 2011 Sep;134(1):107. doi: 10.1111/j.1365-2567.2011.03491.x PMID: 18800988 Free PMC article. Retracted.

4

T cell recognition of desmoglein 3 peptides in patients with pemphigus vulgaris and healthy individuals.

Veldman CM, Gebhard KL, Uter W, Wassmuth R, Grötzinger J, Schultz E, Hertl M. Veldman CM, et al. J Immunol. 2004 Mar 15;172(6):3883-92. doi: 10.4049/jimmunol.172.6.3883. J Immunol. 2004. PMID: 15004196

5

Ex vivo analysis of desmoglein 1-responsive T-helper (Th) 1 and Th2 cells in patients with pemphigus foliaceus and healthy individuals.

Gebhard KL, Veldman CM, Wassmuth R, Schultz E, Schuler G, Hertl M. Gebhard KL, et al. Exp Dermatol. 2005 Aug;14(8):586-92. doi: 10.1111/j.0906-6705.2005.00329.x. Exp Dermatol. 2005. PMID: 16026580

6

Dichotomy of autoreactive Th1 and Th2 cell responses to desmoglein 3 in patients with pemphigus vulgaris (PV) and healthy carriers of PV-associated HLA class II alleles.

Veldman C, Stauber A, Wassmuth R, Uter W, Schuler G, Hertl M. Veldman C, et al. J Immunol. 2003 Jan 1;170(1):635-42. doi: 10.4049/jimmunol.170.1.635. J Immunol. 2003. PMID: 12496453

7

T-cellular autoimmunity against desmogleins in pemphigus, an autoantibody-mediated bullous disorder of the skin.

Hertl M, Veldman C. Hertl M, et al. Among authors: veldman c. Autoimmun Rev. 2003 Sep;2(5):278-83. doi: 10.1016/s1568-9972(03)00035-1. Autoimmun Rev. 2003. PMID: 12965179 Review.

8

Inhibition of the transcription factor Foxp3 converts desmoglein 3-specific type 1 regulatory T cells into Th2-like cells.

Veldman C, Pahl A, Beissert S, Hansen W, Buer J, Dieckmann D, Schuler G, Hertl M. Veldman C, et al. J Immunol. 2006 Mar 1;176(5):3215-22. doi: 10.4049/jimmunol.176.5.3215. J Immunol. 2006. PMID: 16493082

9

T cell control in autoimmune bullous skin disorders.

Hertl M, Eming R, Veldman C. Hertl M, et al. Among authors: veldman c. J Clin Invest. 2006 May;116(5):1159-66. doi: 10.1172/JCI28547. J Clin Invest. 2006. PMID: 16670756 Free PMC article. Review.

10

Pemphigus--paradigm of autoantibody-mediated autoimmunity.

Hertl M, Veldman C. Hertl M, et al. Among authors: veldman c. Skin Pharmacol Appl Skin Physiol. 2001 Nov-Dec;14(6):408-18. doi: 10.1159/000056375. Skin Pharmacol Appl Skin Physiol. 2001. PMID: 11598441 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22 results

Search Page

Filters